ImpediMed Limited
IPDQF
$0.01
$0.00-17.65%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.32% | 14.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.32% | 14.30% | |||
| Cost of Revenue | 0.33% | -6.96% | |||
| Gross Profit | 0.32% | 18.16% | |||
| SG&A Expenses | 0.32% | 9.82% | |||
| Depreciation & Amortization | 0.32% | -8.61% | |||
| Other Operating Expenses | 0.31% | -11.28% | |||
| Total Operating Expenses | 0.32% | 3.47% | |||
| Operating Income | -0.32% | 2.90% | |||
| Income Before Tax | -0.32% | -3.76% | |||
| Income Tax Expenses | 0.00% | -4.17% | |||
| Earnings from Continuing Operations | -0.32% | -3.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.32% | -3.75% | |||
| EBIT | -0.32% | 2.90% | |||
| EBITDA | -0.32% | 20.95% | |||
| EPS Basic | 0.00% | -5.26% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | -5.26% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.94% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||